The medication works gradually, helping to reduce hunger and increase feelings of fullness, making it easier to stick to healthier eating habits and manage calorie intake
Key facts: Medicaid launch : as early as May 2026 Participation : voluntary for states states must opt in Pricing : CMS negotiates directly with Eli Lilly (Zepbound/Mounjaro) and Novo Nordisk (Wegovy/Ozempic)
St Bernard Drugs does not bill insurance for compounded medications, but we can give you a Universal Claim Form to submit to your insurance to claim reimbursement
standard obesity coverage eliminated January 1, 2026
ColonBroom is not intended as a "quick fix" or guaranteed weight-loss solution
The monitoring schedule should be individualized based on treatment indication, baseline comorbidities, and patient-specific factors, though general frameworks provide useful guidance